Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 J&J to Cut 2% of Workforce | Contract Pharma

What are you searching for?

Sign in
Breaking News

J&J to Cut 2% of Workforce

Plans to restructure medical devices business

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Johnson & Johnson plans to eliminate approximately 3,000 jobs in the next two years as part of an effort to restructure its medical devices business. This amounts to more than 2% of its global workforce and 4% – 6% percent of its medical device employees.
 
“These actions recognize the changing needs of the global medical device market,” said Gary Pruden, chairman of Johnson & Johnson’s medical device unit, in a statement.
 
The restructuring focuses on the company’s orthopedics, surgery and cardiovascular businesses and does not impact consumer medical devices, pharmaceuticals or consumer businesses.
 
The company aims to save $800 million to $1 billion annually, which would mostly be realized by the end of 2018. The company said it is considering “strategic options” for underperforming business units.
 
J&J will book a fourth-quarter charge of about $600 million in connection with the restructuring.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters